Market revenue in 2023 | USD 14.9 million |
Market revenue in 2030 | USD 27.8 million |
Growth rate | 9.3% (CAGR from 2023 to 2030) |
Largest segment | Transrectal |
Fastest growing segment | Transperineal |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Transrectal, Transperineal |
Key market players worldwide | Koninklijke Philips NV, Hitachi Ltd, Esaote, Eigen, MedCom, Koelis, Focal Healthcare, UC Care |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to fusion biopsy market will help companies and investors design strategic landscapes.
Transrectal was the largest segment with a revenue share of 87.25% in 2023. Horizon Databook has segmented the South Korea fusion biopsy market based on transrectal, transperineal covering the revenue growth of each sub-segment from 2018 to 2030.
In 2015, the Korean Cancer Association recorded 214,701 new cases. The risk of developing cancer from birth to life in 2015 was found to be 35.30%. The Korean government established the National Care Center (NCC) with the help of the Ministry of Health and Welfare (MOHW).
Through this center, the Korean government provides education, research, and clinical care pertaining to cancer. The NCC primarily consists of three main divisions: The Research Institute, the Hospital, and the National Cancer Control Research Institute (NCCRI).
Therefore, an increase in incidence of prostate cancer and initiatives undertaken by the Korean government are expected to drive the development of fusion biopsy and aid overall market growth.
Horizon Databook provides a detailed overview of country-level data and insights on the South Korea fusion biopsy market , including forecasts for subscribers. This country databook contains high-level insights into South Korea fusion biopsy market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account